Prognostic Significance of DR-70 Levels in Dysplastic Colorectal Polyps

被引:6
|
作者
Yesil, Atakan [1 ]
Abanonu, Gul Babacan [2 ]
Colak, Yasar [3 ]
Paker, Nurcan [4 ]
Gonen, Can [1 ]
机构
[1] Haydarpasa Numune Training & Res Hosp, Dept Gastroenterol, Istanbul, Turkey
[2] Haydarpasa Numune Training & Res Hosp, Dept Internal Med, Istanbul, Turkey
[3] Medeniyet Univ, Dept Gastroenterol, Istanbul, Turkey
[4] Duzen Labs, Istanbul, Turkey
关键词
D-DIMER LEVEL; CARCINOEMBRYONIC ANTIGEN; CANCER; IMMUNOASSAY; SURVEILLANCE; RESECTION; UPDATE; TRACT; SERUM; FDP;
D O I
10.1155/2013/275392
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. To investigate the relationship between DR-70 serum levels and dysplastic colon polyps. Materials and Methods. A total of 130 patients with adenomatous polyps detected by colonoscopy and divided into two groups including low versus high grade polyp, along with 50 healthy blood donors were included in the study. Blood samples from each participant were analyzed for serum CEA and DR-70 levels. Results. No statistically significant differences were observed between the two groups in terms of age or gender. The median DR-70 level was 0.5 mu g/mL in the healthy control group and 1.1 mu g/mL in group 1b (i.e., the high grade polyp) (P < 0.001). DR-70 was higher in group 1b as compared to group 1a (P < 0.001). However, the median DR-70 values for the low grade polyp group (i.e., group 1a) and the control group were similar (P = 0.067). In order to determine independent predictors of high grade dysplasia, CEA, DR-70, polyp size, and age parameters were subjected to multiple logistical regression analyses via the Enter method; the model was statistically significant (P < 0.001). Conclusions. DR-70, a marker used to measure FDP, which is generated by all major cancers, is a potential marker to identify patients with advanced adenomatous polyps, that is, precursors of colorectal cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Clinical significance of peripheral blood UL16 and DR-70 for the early diagnosis and prognostic evaluation of colorectal cancer
    Zong, Zhi-Ping
    Wu, Chen
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (09)
  • [2] PROGNOSTIC SIGNIFICANCE OF COLORECTAL POLYPS
    MURRAY, AJ
    PRENSA MEDICA ARGENTINA, 1974, 61 (24): : 739 - 742
  • [3] Serum AMDL DR-70 levels: a new concept in the diagnosis and follow-up of colorectal carcinoma
    Saridemir, Serdar
    Gueven, Hikmet E.
    Aksel, Buelent
    Dogan, Luetfi
    BIOMARKERS IN MEDICINE, 2020, 14 (08) : 621 - 628
  • [4] DR-70 immunoassay in gastric cancer
    Koklu, Hayretdin
    Koklu, Seyfettin
    Ozturk, Omer
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2016, 27 (01): : 88 - 88
  • [5] Serum DR-70 as Biomarker in Breast Cancer
    Buldanli, Mehmet Zeki
    Ozemir, Ibrahim Ali
    Colapkulu, Nuray
    Baysal, Hakan
    Ekinci, Ozgur
    Yener, Oktay
    Kahraman, Nevin Genc
    Alimoglu, Orhan
    INDIAN JOURNAL OF SURGERY, 2022, 84 (06) : 1284 - 1291
  • [6] DR-70 immunoassay for the surveillance of hepatocellular carcinoma
    Lin, Shan-Zu
    Chen, Chun-Chia
    Lee, Kuei-Chuan
    Tseng, Chih-Wei
    Lin, Hsiao-Yi
    Chen, Yi-Chou
    Lin, Han-Chieh
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (03) : 547 - 552
  • [7] DR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms
    Ke, Chiao-Hsu
    Lin, Chen-Si
    Sio, Ka-Mei
    Wu, Chun-Hung
    Xia, Yuan-Yuan
    Lee, Jih-Jong
    Hu, Chin-Hao
    Liu, Cheng-Chi
    Liaw, Bor-Song
    Cheng, Chiao-Lei
    Lin, Keng-Hsuan
    Wang, Yu-Shan
    VETERINARY QUARTERLY, 2024, 44 (01) : 1 - 10
  • [8] Serum DR-70 as Biomarker in Breast Cancer
    Mehmet Zeki Buldanlı
    İbrahim Ali Özemir
    Nuray Çolapkulu
    Hakan Baysal
    Özgür Ekinci
    Oktay Yener
    Nevin Genç Kahraman
    Orhan Alimoğlu
    Indian Journal of Surgery, 2022, 84 : 1284 - 1291
  • [9] DR-70 immunoassay and malignant pleural effusion
    Joob, Beuy
    Wiwantikit, Viroj
    LUNG INDIA, 2014, 31 (01) : 91 - 91
  • [10] POTENTIAL USE OF SERUM AMDL DR-70 LEVELS AS A TUMOR MARKER FOR BREAST CANCER
    Aksel, Bulent
    Dogancayir, Firuzeilayda
    ACTA MEDICA MEDITERRANEA, 2019, 35 (04): : 1779 - 1782